Menu
Personal menu
Search
Cigalah HealthCare Platform
Close
Close
Close
All categories
    • Home /
    • YESCARTA (axicabtagene ciloleucel) is a CD19-directed genetically modified autologous T cell immunotherapy

    YESCARTA (axicabtagene ciloleucel) is a CD19-directed genetically modified autologous T cell immunotherapy

    Be the first to review this product
    YESCARTA (axicabtagene ciloleucel) is a CD19-directed genetically modified autologous T cell immunotherapy
    SKU: 1750002-00
    YESCARTA (axicabtagene ciloleucel) is a CD19-directed genetically modified autologous T cell immunotherapy
    Ship to
    *
    *
    Shipping Method
    Name
    Estimated Delivery
    Price
    No shipping options
    YESCARTA (axicabtagene ciloleucel) is a CD19-directed genetically modified autologous T cell immunotherapy
    • Only registered users can write reviews
    *
    *
    Bad
    Excellent
    *
    *
    *
    Information
    Customer service
    Copyright © 2025 Cigalah HealthCare Ordering. All rights reserved.